![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Bentham Science Publishers
E-ISSN: 1875-5917|5|1|11-26
ISSN: 1568-0088
Source: Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.5, Iss.1, 2005-01, pp. : 11-26
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neurodegeneration in multiple sclerosis
PHARMAKON, Vol. 2, Iss. 6, 2014-11 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Neurodegeneration and Neuroprotection in Multiple Sclerosis
Current Pharmaceutical Design, Vol. 18, Iss. 29, 2012-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Therapeutic developments in multiple sclerosis
By Goodin D.S.
Expert Opinion on Investigational Drugs, Vol. 9, Iss. 4, 2000-04 ,pp. :